Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes

We previously showed that the choice of levofloxacin or moxifloxacin for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-TB) did not affect sputum culture conversion at 3 months of treatment. To compare final treatment outcomes between patients with MDR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the American Thoracic Society 2016-03, Vol.13 (3), p.364-370
Hauptverfasser:	Kang, Young Ae, Shim, Tae Sun, Koh, Won-Jung, Lee, Seung Heon, Lee, Chang-Hoon, Choi, Jae Chol, Lee, Jae Ho, Jang, Seung Hun, Yoo, Kwang Ha, Jung, Ki Hwan, Kim, Ki Uk, Choi, Sang Bong, Ryu, Yon Ju, Kim, Kyung Chan, Um, Soojung, Kwon, Yong-Soo, Kim, Yee Hyung, Choi, Won-Il, Jeon, Kyeongman, Hwang, Yong Il, Kim, Se Joong, Lee, Hyun-Kyung, Heo, Eunyoung, Yim, Jae-Joon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Female Fluoroquinolones - administration & dosage Fluoroquinolones - adverse effects Humans Levofloxacin - administration & dosage Levofloxacin - adverse effects Logistic Models Male Middle Aged Multivariate Analysis Proportional Hazards Models Prospective Studies Republic of Korea Treatment Outcome Tuberculosis, Multidrug-Resistant - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!